Japanese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Study of Some Risk Factors for Developing RA

登録ユーザーのみが記事を翻訳できます
ログインサインアップ
リンクがクリップボードに保存されます
状態まだ募集していません
スポンサー
Assiut University

キーワード

概要

Introduction Rheumatoid arthritis (RA), a chronic autoimmune disease of unknown etiology, .If not managed early , RA can result in irreversible, painful, and disabling joint damage. RA is often diagnosed using predefined criteria that necessitate clinical, laboratory, and radiologic examinations.
The prevalence of RA among adults is approximately 1-2% affecting women two to four times more often than men.Although RA risk increases with age, it can manifest at any stage of life, including childhood, adolescence, and adulthood.(1-4)( Karlson EW, Mandl LA, Hankinson SE, Grodstein F, Karlson EW, Mandl LA, Hankinson SE, Grodstein F., Karlson EW, Mandl LA, Hankinson SE, Grodstein F, Karlson EW, Mandl LA, Hankinson SE, Grodstein F) To date, a limited number of RA risk or protective factors have been identified, with genetic predisposition to autoimmune response (eg, HLA-DR4 gene) and repeated environmental exposures (eg, tobacco smoke) playing a major role.(3)(Karlson EW, Mandl LA, Hankinson SE, Grodstein F) Heritability of RA is well-established because the lifetime risk of RA and related autoimmune diseases (namely, systemic lupus erythematosus, ankylosing spondylitis, scleroderma, Sjo¨gren's syndrome, and hypothyroidism) increases 1.5 to 3 times in children of women diagnosed with RA.

説明

Patients will answer the following the questationnaire:

Name age gender

1 Socio echonomic status (average salary \year) (Education) (Job) (residence)

1. Body mass index (height\wt2)

2. Disease duration in months.

3. Smoking (yes) (No) Passive smoker Ex smoker

4. Reproductive history:

- age of menarche….

- menstrual cycle….. regular or not……. P / C

- How many pregnancies…….. living.

- Abortion.

- patient age at first birth (….).

- breast feeding…..(yes)…….(no)

- use of contraceptives (yes)…pills injections IUD (N0)……

- Does patient get pregnant during disease?...(Yes)……(no)….. Does the arthritis improved (…)or got worse (…..) -flared during the purpurium.(yes) … (No)

- age of menupause…. 10 Exposure to sun….(yes)…..(No) 11 -Theraputic history… (Newly diagnosed)

- (Previously diagnosed),

- Does the patient receiving ttt? (yes) (Steroid)……. (NSAIDS)……. (2nd line drugs) (.Methotrexat(.…), Leflonamide (….) Hydroquine(….) (NO)……..

- The study will include 100 patients fullfilling ACR 2010

- Patients well subjected to

- Through clinical examination with emphysis on joints examination

- venous blood sampling will withdrawn and the following investigations will be done.

- Serum VIT D level

- Serum calcium and phosphorus

- Anti cyclic citrullinated peptide.

- ESR

日付

最終確認済み: 07/31/2018
最初に提出された: 07/10/2018
提出された推定登録数: 08/07/2018
最初の投稿: 08/09/2018
最終更新が送信されました: 08/07/2018
最終更新日: 08/09/2018
実際の研究開始日: 08/14/2018
一次完了予定日: 09/14/2018
研究完了予定日: 09/19/2018

状態または病気

Rheumatoid Arthritis

段階

-

アームグループ

介入/治療
Rheumatoid arthritis patients
complete blood count, Erythrocyte sedimentation rate, C reactive protien ,rheumatoid factor,Anti cyclic citrullinated peptide antibody
healthy control
complete blood count, Erythrocyte sedimentation rate, C reactive protien ,rheumatoid factor,Anti cyclic citrullinated peptide antibody

適格基準

研究に適格な性別All
サンプリング方法Non-Probability Sample
健康なボランティアを受け入れるはい
基準

Inclusion Criteria:

- patients with rheumatoid arthritis diagnosed based on american collegue of rheumatology 2010 criteria with no history of vit D therapy

Exclusion Criteria:

- patients with rheumatoid arthritis on vit D supplements

- patient refusal

- patient not fullfill american collegue of rheumatology 2010 citeria for diagnosis pf rheumatoid arthritis

結果

主な結果の測定

1. vitamin D level [one month]

blood sample using ELISA kits

2. Body mass index [one month]

weight in kg/m^2

二次的な結果の測定

1. Anti cyclic citrullnated peptide antibodies [one month]

blood sample using ELISA

2. Rheumatoid factor antibody [one month]

blood sample

Facebookページに参加する

科学に裏打ちされた最も完全な薬草データベース

  • 55の言語で動作します
  • 科学に裏打ちされたハーブ療法
  • 画像によるハーブの認識
  • インタラクティブGPSマップ-場所にハーブをタグ付け(近日公開)
  • 検索に関連する科学出版物を読む
  • それらの効果によって薬草を検索する
  • あなたの興味を整理し、ニュース研究、臨床試験、特許について最新情報を入手してください

症状や病気を入力し、役立つ可能性のあるハーブについて読み、ハーブを入力して、それが使用されている病気や症状を確認します。
*すべての情報は公開された科学的研究に基づいています

Google Play badgeApp Store badge